Literature DB >> 18691604

Looking for the role of cannabinoid receptor heteromers in striatal function.

Sergi Ferré1, Steven R Goldberg, Carme Lluis, Rafael Franco.   

Abstract

The introduction of two concepts, "local module" and "receptor heteromer", facilitates the understanding of the role of interactions between different neurotransmitters in the brain. In artificial cell systems, cannabinoid CB(1) receptors form receptor heteromers with dopamine D2, adenosine A2A and mu opioid receptors. There is indirect but compelling evidence for the existence of the same CB1 receptor heteromers in striatal local modules centered in the dendritic spines of striatal GABAergic efferent neurons, particularly at a postsynaptic location. Their analysis provides new clues for the role of endocannabinoids in striatal function, which cannot only be considered as retrograde signals that inhibit neurotransmitter release. Recent studies using a new method to detect heteromerization of more than two proteins, which consists of sequential BRET-FRET (SRET) analysis, has demonstrated that CB1, D2 and A2A receptors can form heterotrimers in transfected cells. It is likely that functional CB1-A2A-D2 receptor heteromers can be found where they are highly co-expressed, in the dendritic spines of GABAergic enkephalinergic neurons. The functional properties of these multiple receptor heteromers and their role in striatal function need to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691604      PMCID: PMC2635338          DOI: 10.1016/j.neuropharm.2008.06.076

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  100 in total

1.  Inhibitory control of neostriatal projection neurons by GABAergic interneurons.

Authors:  T Koós; J M Tepper
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

Review 2.  Volume transmission in the CNS and its relevance for neuropsychopharmacology.

Authors:  M Zoli; A Jansson; E Syková; L F Agnati; K Fuxe
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

3.  Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely-moving rats.

Authors:  Holly M Baseski; Christopher J Watson; Nicholas A Cellar; Jonathan G Shackman; Robert T Kennedy
Journal:  J Mass Spectrom       Date:  2005-02       Impact factor: 1.982

Review 4.  Cannabinoid receptor homo- and heterodimerization.

Authors:  Ken Mackie
Journal:  Life Sci       Date:  2005-08-19       Impact factor: 5.037

5.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?

Authors:  Christopher S Kearn; Katherine Blake-Palmer; Emma Daniel; Ken Mackie; Michelle Glass
Journal:  Mol Pharmacol       Date:  2005-02-14       Impact factor: 4.436

Review 6.  Pharmacological and biochemical interactions between opioids and cannabinoids.

Authors:  J Manzanares; J Corchero; J Romero; J J Fernández-Ruiz; J A Ramos; J A Fuentes
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

7.  Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.

Authors:  A Giuffrida; L H Parsons; T M Kerr; F Rodríguez de Fonseca; M Navarro; D Piomelli
Journal:  Nat Neurosci       Date:  1999-04       Impact factor: 24.884

8.  Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent.

Authors:  S Martin-Schild; A A Gerall; A J Kastin; J E Zadina
Journal:  J Comp Neurol       Date:  1999-03-22       Impact factor: 3.215

9.  Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Authors:  Attila Köfalvi; Ricardo J Rodrigues; Catherine Ledent; Ken Mackie; E Sylvester Vizi; Rodrigo A Cunha; Beáta Sperlágh
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

10.  Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.

Authors:  Mikael Andersson; Alessandro Usiello; Anders Borgkvist; Laura Pozzi; Cecilia Dominguez; Allen A Fienberg; Per Svenningsson; Bertil B Fredholm; Emiliana Borrelli; Paul Greengard; Gilberto Fisone
Journal:  J Neurosci       Date:  2005-09-14       Impact factor: 6.167

View more
  40 in total

Review 1.  Adenosine-cannabinoid receptor interactions. Implications for striatal function.

Authors:  Sergi Ferré; Carme Lluís; Zuzana Justinova; César Quiroz; Marco Orru; Gemma Navarro; Enric I Canela; Rafael Franco; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers.

Authors:  Gemma Navarro; Sergi Ferré; Arnau Cordomi; Estefania Moreno; Josefa Mallol; Vicent Casadó; Antoni Cortés; Hanne Hoffmann; Jordi Ortiz; Enric I Canela; Carme Lluís; Leonardo Pardo; Rafael Franco; Amina S Woods
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

5.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

Review 6.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

7.  Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission.

Authors:  Sergi Ferré; Marco Orrú; Xavier Guitart
Journal:  J Caffeine Res       Date:  2013-06

8.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

9.  The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing.

Authors:  T Seif; A Makriyannis; G Kunos; A Bonci; F W Hopf
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

10.  A putative 'pre-nervous' endocannabinoid system in early echinoderm development.

Authors:  G A Buznikov; L A Nikitina; V V Bezuglov; M E Y Francisco; G Boysen; I N Obispo-Peak; R E Peterson; E R Weiss; H Schuel; B R S Temple; A L Morrow; J M Lauder
Journal:  Dev Neurosci       Date:  2009-11-12       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.